publié le 06/02/2023 à 18:00 par Arix Bioscience PLC (isin : GB00BD045071)

Director/PDMR Shareholding

Arix Bioscience PLC (ARIX)
Director/PDMR Shareholding

06-Feb-2023 / 17:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

Arix Bioscience plc
("Company")

PDMR notification & Director Shareholding

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company has been notified that Peregrine Moncreiffe, Director and Chairman of the Company purchased 200,000 Ordinary shares of 0.001 pence each in the Company (“Shares”) on 06 February 2023 at a price of 108.5 pence per share.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Peregrine Moncreiffe
2	Reason for the notification
a)	Position/status	Non-Executive Director and Chair of the Board
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Arix Bioscience plc Ordinary shares of 0.001 pence each
	Identification code	GB00BD045071
b)	Nature of the transaction	Share purchase
	Price(s) and volume(s)		Price(s)	Volume(s)
			£1.085	200,000
d)	Aggregated information
	- Aggregated volume	200,000
	- Price	£217,000.00
e)	Date of the transaction	06 February 2023
f)	Place of the transaction	Outside a trading venue

For further information please contact:
Kin Company Secretarial Limited, Company Secretary
+44 20 8819 6486


ISIN:	GB00BD045071
Category Code:	DSH
TIDM:	ARIX
LEI Code:	213800OVT3AHQCXNIX43
OAM Categories:	3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:	221131
EQS News ID:	1552927


End of Announcement	EQS News Service

Voir toutes les actualités de Arix Bioscience PLC